The process improvement of manufacturing active pharmaceutical ingredients

被引：0
|
作者：
Chen, Chiwei [1 ]
Pao, Lu-Sheng [2 ]
Lei, Hong [1 ]
Hsieh, Meng-Zhi [3 ]
机构：
[1] Zhaoqing Univ, Coll Econ & Management, Zhaoqing, Guangdong, Peoples R China
[2] Sanming Univ, Coll Econ & Management, Fujian, Peoples R China
[3] Tajen Univ, Dept Pharm, Pingtung, Taiwan
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
105
引用
下载
收藏
页码：57 / 58
页数：2
相关论文
共 50 条
  • [21] Current good manufacturing practice design trends in active pharmaceutical ingredients facilities
    Angelucci, LA
    DRUG INFORMATION JOURNAL, 1999, 33 (03): : 739 - 746
  • [22] Theoretical approaches to physical transformations of active pharmaceutical ingredients during manufacturing processes
    Morris, KR
    Griesser, UJ
    Eckhardt, CJ
    Stowell, JG
    ADVANCED DRUG DELIVERY REVIEWS, 2001, 48 (01) : 91 - 114
  • [23] Synthetic challenges in the development of commercial manufacturing processes for two active pharmaceutical ingredients
    Savage, Scott
    Domagalski, Nathan
    Hobson, Lindsay
    Jones, Scott
    Mack, Brendan
    Qiu, Yuping
    Ramirez, Antonio
    Waltermire, Robert
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
  • [24] Continuous-Flow TechnologyA Tool for the Safe Manufacturing of Active Pharmaceutical Ingredients
    Gutmann, Bernhard
    Cantillo, David
    Kappe, C. Oliver
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2015, 54 (23) : 6688 - 6728
  • [25] Current Good Manufacturing Practice Design Trends in Active Pharmaceutical Ingredients Facilities
    Louis A. Angelucci
    Drug information journal : DIJ / Drug Information Association, 1999, 33 : 739 - 746
  • [26] A RISK-BASED APPROACH TO MANAGING ACTIVE PHARMACEUTICAL INGREDIENTS IN MANUFACTURING EFFLUENT
    Caldwell, Daniel J.
    Mertens, Birgit
    Kappler, Kelly
    Senac, Thomas
    Journel, Romain
    Wilson, Peter
    Meyerhoff, Roger D.
    Parke, Neil J.
    Mastrocco, Frank
    Mattson, Bengt
    Murray-Smith, Richard
    Dolan, David G.
    Straub, Juerg Oliver
    Wiedemann, Michael
    Hartmann, Andreas
    Finan, Douglas S.
    ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY, 2016, 35 (04) : 813 - 822
  • [27] Prequalification of active pharmaceutical ingredients
    WHO EXPERT COMMITTEE ON SPECIFICATIONS FOR PHARMACEUTICAL PREPARATIONS, 2015, 992 : 37 - 37
  • [28] Prequalification of active pharmaceutical ingredients
    WHO EXPERT COMMITTEE ON SPECIFICATIONS FOR PHARMACEUTICAL PREPARATIONS, 2013, 981 : 29 - 29
  • [29] Application of crystallization technologies to process development and manufacture of active pharmaceutical ingredients
    Rose, PR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U3344 - U3345
  • [30] GMP requirements for quality control/assurance in the manufacturing of active pharmaceutical ingredients examples from manufacturing plants
    Schönborn, C
    PHARMAZEUTISCHE INDUSTRIE, 2003, 65 (07): : 695 - +
12345